CoChat

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Gene Therapy With Adeno-Associated Virus Vector 5-Human Factor IX in Adults With Hemophilia B

Open access

Abstract

Key Points: AAV5 liver-directed wild-type hFIX gene transfer was well tolerated and clinically effective in severe and moderate-severe hemophilia B. No cellular immune responses to the AAV5 vector were detected, and FIX expression levels were stable for the entire observation period.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2017-09-804419

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 3

  1. Pasi, 2017, Interim results from a phase 1/2 AAV5-FVIII gene transfer in patients with severe hemophilia A, Res Pract Thromb Haemost., 1, 1
  2. Chapin, 2017, An analysis of bleeding rates and factor IX consumption in the phase I/II BAX 335 gene therapy trial in subjects with hemophilia B, Res Pract Thromb Haemost., 1, 144
  3. Nathwani, 2016, Progress for gene therapy for hemophilia. European Society of Gene and Cell Therapy

Cited by

See all 308

Metadata

Authors
Miesbach, W., Meijer, K., Coppens, M., Kampmann, P., Klamroth, R., Schutgens, R., Tangelder, M., Castaman, G., Schwäble, J., Bonig, H., Seifried, E., Cattaneo, F., Meyer, C., & Leebeek, F. W. G.
Affiliations
  • University Hospital Frankfurt (DE)
  • University Medical Center Groningen (NL)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Rigshospitalet (DK)
  • Vivantes Klinikum (DE)
  • Utrecht University (NL)
  • UniQure (Netherlands) (NL)
  • Azienda Ospedaliero-Universitaria Careggi (IT)
  • German Red Cross (DE)
  • University of Washington (US)
  • Chiesi (Italy) (IT)
  • Erasmus MC (NL)
Venue
Blood
Published
2018-03-01
Volume
131
Issue
9
Pages
1022-1031
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2773565340
Cited by
301
References
29
Citations by year
2026: 9 · 2025: 26 · 2024: 26 · 2023: 35 · 2022: 44 · 2021: 44 · 2020: 46 · 2019: 40 · 2018: 30
FWCI
24.45
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
Keywords
gene therapy, human factor IX, hemophilia B, factor IX activity, alanine aminotransferase elevation, adults
MeSH terms
Dependovirus, Adult, Hemophilia B, Factor IX, Female, Genetic Vectors, Humans, Male, Prednisolone, Genetic Therapy, Parvovirinae

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gene Therapy With Adeno-Associated Virus Vector 5-Human Factor IX in Adults With Hemophilia B. https://app.cochat.ai/papers/10.1182/blood-2017-09-804419
The paper
Miesbach, W., Meijer, K., Coppens, M., Kampmann, P., Klamroth, R., Schutgens, R., Tangelder, M., Castaman, G., Schwäble, J., Bonig, H., Seifried, E., Cattaneo, F., Meyer, C., & Leebeek, F. W. G. (2018). Gene Therapy With Adeno-Associated Virus Vector 5-Human Factor IX in Adults With Hemophilia B. Blood. https://doi.org/10.1182/blood-2017-09-804419

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.